OFFICIAL-SOURCE RECALL · AUSTRALIA
MEDICIANZ MUPIROCIN OINTMENT Mupirocin 2%w/w Tube Recall: Classification Class II Reason for the Action
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- MEDICIANZ MUPIROCIN OINTMENT Mupirocin 2%w/w Tube
- Manufacturer
- See official notice
- Lot number
- numbers, Numbers, S062409, used, S082414
- Batch number
- numbers, S062409, used, S082414
- Date code
- dates, Dates, date
- Expiration date
- dates, Dates, date
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
Classification Class II Reason for the Action During ongoing stability testing, an out of specification (OOS) result was obtained for the stability batch (Batch No. S062409.1) at the 24-month testing point for both the assay (content) of Mupirocin and related impurities. Following initial evaluation, the affected batches have been identified as those manufactured within a defined period between June 2024 and September 2024. The event is traceable to a single root cause associated with a specific excipient batch used temporarily during that timeframe. All subsequent batches fall outside the scope of this recall investigation and are not affected. Based on the preliminary assessment, no risk to patients is expected, as the concerned batches are close to their expiry date, and the probability of the
Hazard
Classification Class II Reason for the Action During ongoing stability testing, an out of specification (OOS) result was obtained for the stability batch (Batch No. S062409.1) at the 24-month testing point for both the assay (content) of Mupirocin and related impurities. Following initial evaluation, the affected batches have been identified as those manufactured within a defined period between June 2024 and September 2024. The event is traceable to a single root cause associated with a specific excipient batch used temporarily during that timeframe. All subsequent batches fall outside the scope of this recall investigation and are not affected. Based on the preliminary assessment, no risk to patients is expected, as the concerned batches are close to their expiry date, and the probability of the
Official recall notice
MEDICIANZ MUPIROCIN OINTMENT Mupirocin 2%w/w Tube
Agency: Therapeutic Goods Administration
Official publication date: August 18, 2026
Read the official AU_TGA_DRAC recall notice →Scan products you own
Scan products you own once and let RecallGuard monitor future official recalls.
Scan & Monitor Products